eQ Oyj
eQ Plc Investor news
28 January 2021, at 11:00 am
eQ Plc will publish its January-December 2020 Financial Statements Release on Friday 5 February 2021 at around 8:00 a.m. eQ will present the 2020 result to press, investors and analysts in a press conference to be held on 5 February 2021 at 11:00 am. The press conference will held at eQ's head office in Helsinki, address Aleksanterinkatu 19, 5th floor, 00100 Helsinki and it is also possible to participate via webcast. The webcast participation requires a registration.
The press conference will be held in Finnish. The presentation material can be viewed at eQ's website after the press conference has begun. To join the conference, please register with iida.tuunainen@eq.fi.
eQ Plc
Janne Larma, CEO
Additional information: Janne Larma, CEO, tel. +358 9 6817 8920
Distribution: Nasdaq Helsinki, www.eQ.fi, media
eQ Group is a Finnish group of companies specialising in asset management and corporate finance business. eQ Asset Management offers a wide range of asset management services (including private equity funds and real estate asset management) for institutions and individuals. The assets managed by the Group total approximately EUR 8.7 billion. Advium Corporate Finance, which is part of the Group, offers services related to mergers and acquisitions, real estate transactions and equity capital markets.
More information about the Group is available on our website at www.eQ.fi.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
KH Group Oyj19.9.2025 14:20:51 CEST | Press release
Inside information: Carl Haglund appointed as CEO of KH Group Plc
F. Hoffmann-La Roche Ltd19.9.2025 14:15:00 CEST | Press release
CHMP recommends EU approval of Roche’s subcutaneous formulation of Lunsumio for people with relapsed or refractory follicular lymphoma
Ipsen Pharma19.9.2025 13:59:15 CEST | Press release
Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC
Alvotech19.9.2025 13:45:00 CEST | Press release
Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
Yacht Club de Monaco19.9.2025 13:11:39 CEST | Press release
At Yacht Club de Monaco the 5th Monaco Smart & Sustainable Marina Rendezvous
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom